848 documents showing 121–180
Phillips 66 PSX
Phillips 66's conglomerate hides world-class midstream worth $40bn+; spinning midstream, closing the $3.75/bbl refining gap to Valero, and refreshing the board can lift PSX from $120 to $200+.
N5
V4
C4
⌂
◫
”
⚑
Solventum Corporation SOLV
Solventum's post-spin performance collapse is nearly worst-in-class; restoring 3M-era 3-4% growth and 26% margins plus simplifying the portfolio can double shares to $140 by 2027.
N4
V3
C3
⌂
◫
”
⇌
Peloton Interactive PTON
Peloton's overlooked subscription business — 68% gross margins, 1.5% churn — can deliver $400-500M EBITDA once costs are right-sized, implying a $7.50-$31.50 share price versus $5.48 today.
N5
V4
C5
⌂
”
⚑
Pfizer Inc. PFE
Pfizer squandered its $40bn COVID windfall on overpriced M&A while delivering almost none of the 15 promised blockbusters; the Board must hold management accountable.
N5
V4
C4
⌂
◫
”
⚑
Date
Fund
Target
Thesis
Scores
Feb 26, 2025
Oasis Management
Kao Corporation
4452 JT
Kao's world-class beauty brands are squandered by an insular Japanese board; adding five global FMCG outside directors and performance-linked pay can close the gap to L'Oreal and Beiersdorf.
N4
V2
Feb 19, 2025
Spruce Point Capital
Dycom Industries, Inc.
DY
Dycom's premium multiple masks a forensic minefield — undisclosed Frontier related-party revenue, accounting officers with restatement histories, and unexplained DSO expansion — implying 35–55% downside to $79–$119.
N4
V3
Feb 19, 2025
Ancora
United States Steel Corporation
X
U.S. Steel has lagged peers by 227 points under Burritt; with the Nippon deal dead, Ancora's slate would install Stelco-turnaround CEO Kestenbaum to fix the company as a standalone public co.
N4
V4
Feb 18, 2025
Pershing Square
Howard Hughes Holdings Inc.
HHH
HHH trades at a 40% NAV discount with no take-private bidders; Pershing's $900M primary investment at $90 converts it into a modern-day Berkshire Hathaway.
N4
V3
Feb 11, 2025
Elliott Management
Phillips 66
PSX
Phillips 66's conglomerate structure traps value; spinning Midstream, selling the CPChem JV, and fixing refining lifts the stock from $120 to ~$200, with Marathon-style execution reaching $300+.
N5
V4
Feb 11, 2025
Elliott Management
Phillips 66
PSX
Phillips 66's conglomerate structure buries a world-class refiner and >$40bn midstream inside a low-multiple wrapper; spinning midstream, fixing refining and Marathon-style buybacks unlock $200-$300+ per share.
N5
V4
Feb 11, 2025
Pershing Square
Pershing Square Holdings
PSH
Fund-level recap: PSH's 22.9% seven-year NAV CAGR, conservative leverage and PSCM stake sale set up a narrowing of the persistent ~30% discount to NAV.
N2
V3
Feb 11, 2025
Elliott Management
Phillips 66
PSX
Phillips 66's conglomerate hides world-class midstream worth $40bn+; spinning midstream, closing the $3.75/bbl refining gap to Valero, and refreshing the board can lift PSX from $120 to $200+.
N5
V4
Feb 01, 2025
Pershing Square
Uber Technologies
UBER
Uber is a high-quality, network-effect marketplace trading at 29x due to overblown AV fears; 30%+ EPS growth should more than double the stock in 3-4 years.
N3
V4
Feb 01, 2025
99_Other
N/A
other
N1
V2
Jan 29, 2025
Wolfpack Research
Mercury General Corporation
MCY
Mercury General faces >$2bn in LA wildfire losses uncovered by its $1.3bn reinsurance tower, eroding subsidiary capital and risking dividend cuts, capital raises, and regulatory review.
N4
V3
Jan 29, 2025
Kerrisdale Capital
ACM Research, Inc.
ACMR
ACMR trades at 1.1x revenue while its 82%-owned Shanghai subsidiary ACMS trades at 6x — a sum-of-parts gap that implies a 10-bagger as China's WFE self-sufficiency drive accelerates.
N4
V2
Jan 23, 2025
Spruce Point Capital
Construction Partners, Inc.
ROAD
ROAD is a levered Sunbelt asphalt roll-up whose Florida DOT engine is quietly stalling — FOIA shows -22% award decline — and its $1bn Lone Star deal masks the gap; we see 35-50% downside.
N4
V3
Jan 17, 2025
Engine Capital
Smiths Group plc
SMIN
Smiths' four-segment conglomerate structure masks a ~50-60% SOTP discount; the Board should launch a strategic review to sell the company or spin John Crane into a U.S. listing.
N4
V2
Jan 16, 2025
Pershing Square
Fannie Mae / Freddie Mac
FNMA / FMCC
Release Fannie and Freddie from conservatorship at a 2.5% capital standard and IPO them at ~$30+/share; Treasury's warrants generate ~$300bn while shares re-rate 5-6x from ~$6 today.
N5
V4
Jan 16, 2025
Pershing Square
Fannie Mae and Freddie Mac
FNMA/FMCC
press release
N1
V1
Jan 16, 2025
Pershing Square
Fannie Mae and Freddie Mac
FNMA/FMCC
Fannie and Freddie have already repaid Treasury at an 11.6% IRR; releasing them from conservatorship via modest IPOs unlocks ~$300bn of warrant value for taxpayers within two years.
N5
V4
Jan 16, 2025
Spruce Point Capital
PROCEPT BioRobotics Corporation
PRCT
Procept trades at 14x revenue on a false 'all-prostates' TAM; Spruce Point sees channel-stuffing via DSOs at 130 days, no procedure growth, and 30-60% downside to $29-$54.
N4
V3
Jan 15, 2025
Pershing Square
Fannie Mae and Freddie Mac
FNMA/FMCC
press release
N1
V1
Jan 15, 2025
Muddy Waters
FTAI Aviation Ltd.
FTAI
FTAI is a dressed-up engine-leasing business posing as a high-margin MRO — whole-engine sales counted as three modules and intra-segment depreciation transfers fabricate the aerospace-aftermarket story.
N5
V3
Jan 13, 2025
Pershing Square
Howard Hughes Holdings Inc.
HHH
HHH has compounded at just 2.2% over 14 years; merging with Pershing Square Holdco at $85/share converts a market-orphaned real-estate company into a Berkshire-style permanent compounder.
N4
V2
Jan 10, 2025
Scorpion Capital
TransMedics Group Inc
TMDX
TransMedics is a Medicare billing-fraud and kickback racket whose top transplant-center customers are fleeing as cheaper alternatives arrive — Scorpion sets a $0 target.
N5
V3
Jan 09, 2025
Kerrisdale Capital
Red Cat Holdings, Inc.
RCAT
Red Cat's $1bn valuation rests on inflating a $23M/year Army drone contract into a $350M sole-source bonanza, with a factory that can't scale and insiders heading for the exits.
N4
V2
Jan 08, 2025
Trian Partners
Solventum Corporation
SOLV
Solventum's post-spin performance collapse is nearly worst-in-class; restoring 3M-era 3-4% growth and 26% margins plus simplifying the portfolio can double shares to $140 by 2027.
N4
V3
Dec 17, 2024
Engine Capital
Dye & Durham Limited
DND
Engine Capital's six-member slate and OneMove's nominee will replace the entire Dye & Durham board after overwhelming shareholder support forced incumbent directors to resign.
N2
V1
Dec 17, 2024
Oasis Management
Kao Corporation
4452
Kao's Nomination Committee rushed its 2025 AGM director slate two months early to bypass Oasis's five independent candidates — poor governance demanding a reopened, transparent process.
N3
V2
Dec 16, 2024
Spruce Point Capital
Aegon Ltd.
AEG
Aegon's distribution engine WFG is an aggressive MLM run amok with IUL churn, ex-WFG competitor GFI poaching top producers, and sum-of-parts pointing to 25-50% downside.
N5
V4
Dec 11, 2024
Oasis Management
Kao Corporation
4452
Kao's world-class FMCG brands are stalling under a passive Board; Oasis, now holding over 5%, will nominate five independent FMCG directors at the March 2025 AGM to unlock global growth.
N3
V2
Dec 10, 2024
Ancora
Amcor plc (pro forma Amcor-Berry Global combination)
AMCR
The Amcor-Berry merger creates a $36B packaging leader; executing $650M of conservatively-estimated synergies and a re-rate from 8x to 11x EBITDA delivers ~$16/share, a 50-70% upside.
N3
V3
Dec 05, 2024
Oasis Management
Kao Corporation
4452
Kao is a sleeping FMCG giant whose under-ambition, inefficiency, and lack of focus have destroyed EVA; adding five independent directors with FMCG operating experience can unlock peer-level returns.
N4
V4
Dec 01, 2024
Citron Research
Nebius Group
NBIS
Nebius — the de-Russified Yandex remnant now an AI cloud pure-play backed by Nvidia and Accel — is mis-priced ahead of analyst coverage; Citron sees $50+.
N3
V2
Dec 01, 2024
Engine Capital
Dye & Durham Limited
DND
Dye & Durham's Board and CEO Matt Proud destroyed value chasing a $1bn EBITDA target through reckless M&A; Engine's six-director slate and new CEO can triple the share price to $46 in three years.
N5
V4
Dec 01, 2024
Palliser Capital
Rio Tinto
RIO
Rio Tinto's 29-year-old dual-listed structure has destroyed ~US$50bn of value; unifying into a single Ltd-led entity unlocks +27% near-term upside and restores scrip-M&A firepower.
N5
V4
Nov 20, 2024
Muddy Waters
e.l.f. Beauty, Inc.
ELF
ELF's imports collapsed while inventory and revenue kept soaring; reconciling the two suggests $138-188mm of overstated sales and a likely fraud.
N5
V3
Nov 11, 2024
Engine Capital
Dye & Durham Limited
DND
Engine (7.1%) urges Dye & Durham shareholders to replace an entrenched board presiding over management exodus, regulatory investigations, and blocked deals with six independent nominees at the December 17 meeting.
N3
V1
Nov 07, 2024
White Diamond Research
AGBA Group
AGBA
The AGBA/Triller $4B merger is a sham to pump AGBA's stock — both firms are near-bankrupt, the valuation is fiction, and regulators will reject the deal.
N3
V2
Nov 01, 2024
Kerrisdale Capital
Oklo Inc.
OKLO
Oklo is a $3bn pre-revenue SPAC nuclear story whose 5x-lowballed fuel costs, unrealistic 2027 NRC timeline, and inexperienced 'Nuclear Bros' management mean shares should collapse as reality intrudes.
N4
V3
Nov 01, 2024
Engine Capital
Dye & Durham Limited
DND
Engine, a 7.1% holder, nominates six directors to overhaul Dye & Durham's board, replace management, cut leverage to 3x, and close the valuation gap to ~20x EBITDA peers.
N2
V1
Nov 01, 2024
Land & Buildings
Public REIT sector (vs. private real estate)
Public REITs have crushed private real estate over 30 years (9.9% vs 7.0%); with institutions at GFC-low underweights and supply rolling over, listed REITs are a generational buy.
N3
V4
Oct 23, 2024
Greenlight Capital
Peloton Interactive
PTON
Peloton's overlooked subscription business — 68% gross margins, 1.5% churn — can deliver $400-500M EBITDA once costs are right-sized, implying a $7.50-$31.50 share price versus $5.48 today.
N5
V4
Oct 22, 2024
Elliott Management
Southwest Airlines
LUV
Elliott nominates David Cush, former Virgin America CEO, to Southwest's board as part of an eight-director slate to restore the airline's operational and financial performance.
N2
V2
Oct 21, 2024
Bluebell Capital
BP Plc
BP
Bluebell publishes ten pointed questions BP must answer at the 29 Oct 2024 Q3 call, demanding transparency on abandoned EBITDA, production and energy-transition targets and faulting Board oversight.
N3
V2
Oct 18, 2024
Spruce Point Capital
Erie Indemnity Company
ERIE
ERIE's 25% management fee on its sole client — the loss-making Erie Insurance Exchange — looks unsustainable; a 2003-style cut plus peer-level multiple would drive 35-55% downside to $211-$317.
N4
V3
Oct 16, 2024
Engine Capital
Dye & Durham Limited
DND
Engine, owning 7.1% of Dye & Durham, will run a board slate at the 2024 AGM, arguing a refreshed board can close the 8x-vs-18x EBITDA peer gap.
N2
V1
Oct 15, 2024
Elliott Management
Southwest Airlines Co.
LUV
Elliott — ~11% owner of LUV — is running a proxy fight to replace Southwest's board with eight airline-veteran directors and restore the carrier to industry-leading performance.
N2
V3
Oct 07, 2024
Bluebell Capital
BP Plc
BP
BP's ideologically driven 2023 strategy has failed; the Chair and Lead Independent Director must go, and the leaked U-turn on oil output breaches listing rules.
N3
V2
Oct 01, 2024
Starboard Value
Pfizer Inc.
PFE
Pfizer destroyed $20-60bn of value since 2019 despite a $40bn COVID windfall; Starboard wants the board to hold Bourla accountable for peer-median R&D/M&A returns.
N5
V4
Oct 01, 2024
Starboard Value
Salesforce, Inc.
CRM
Salesforce has executed Starboard's 2022 thesis — margins up 1,000bps, stock +99% — but committing to Rule of 50 by FY2028 still unlocks $20+ FCF/share at ~14x.
N4
V3
Oct 01, 2024
Starboard Value
Pfizer Inc.
PFE
Pfizer squandered its $40bn COVID windfall on overpriced M&A while delivering almost none of the 15 promised blockbusters; the Board must hold management accountable.
N5
V4
Oct 01, 2024
Starboard Value
Salesforce, Inc.
CRM
Salesforce's 2022 turnaround delivered +1,000bps margins and +99% stock; Starboard argues further cost discipline plus Agentforce growth can hit the Rule of 50 by FY2028 and $20+ FCF/share.
N4
V3
Sep 26, 2024
Elliott Management
Southwest Airlines
LUV
Elliott, with ~11% of Southwest, calls the management team the worst in airlines and nominates ten independent directors to replace the CEO and restore industry-leading performance.
N3
V3
Sep 25, 2024
Bluebell Capital
BP Plc
BP
BP's 2020 energy-transition strategy is collapsing in serial U-turns and missed targets; removing Chairman Helge Lund and Lead Independent Director Amanda Blanc is essential to restore accountability.
N4
V2
Sep 25, 2024
Engine Capital
Dye & Durham Limited
DND
Engine urges Dye & Durham's board to hold its 2024 AGM in December per TSX rules, or face board changes over entrenchment, delay tactics, and CEO Proud's destructive M&A.
N2
V1
Sep 24, 2024
Elliott Management
Southwest Airlines
LUV
Southwest has become the industry's worst-performing airline under current leadership; Elliott nominates ten independent directors to replace the CEO and restore best-in-class performance.
N3
V3
Sep 24, 2024
Elliott Management
Southwest Airlines Co.
LUV
Southwest's failed leaders are using a poison pill and 'false record dates' to dodge accountability; Elliott will call a special meeting to replace the Board and CEO Bob Jordan.
N3
V2
Sep 24, 2024
Citron Research
Multiple (portfolio update)
AGL short worked: $5 PT set when stock was $25, fell to target on unprofitable model
N2
V2
Sep 20, 2024
Spruce Point Capital
Intuit Inc.
INTU
Intuit is an opaque, consumer-unfriendly SMB software company whose $20bn Credit Karma/Mailchimp blunders and 11x revenue multiple imply 40%-80% downside under CEO Sasan Goodarzi.
N5
V3
Sep 19, 2024
Engine Capital
Dye & Durham Limited
DND
Court dismissal of OneMove litigation removes any remaining excuse to delay the Special Meeting
N2
V2
Sep 13, 2024
Engine Capital
Upwork Inc.
UPWK
Engine argues Upwork is undervalued at ~6.5x EBITDA and that a refreshed board plus fixing the marketplace, focusing Enterprise, cutting bloat and aggressive buybacks unlocks substantial upside.
N4
V2
Sep 11, 2024
Engine Capital
Dye & Durham Limited
DND
Dye & Durham's board broke its no-M&A pledge, re-levered to 5.3x, and lost six executives; shareholders need a Special Meeting and board change to close the peer valuation gap.
N4
V2